Il-28 and il-29 cysteine mutants for treating viral infection

Details for Australian Patent Application No. 2005231476 (hide)

Owner ZymoGenetics, Inc.

Inventors Klucher, Kevin M.; Henderson, Katherine E.; Sivakumar, Pallavur V.; Kindsvogel, Wayne R.

Agent Griffith Hack

Pub. Number AU-B-2005231476

PCT Pub. Number WO2005/097165

Priority 60/634,144 08.12.04 US; 60/559,081 02.04.04 US; 60/609,238 13.09.04 US

Filing date 4 April 2005

Wipo publication date 20 October 2005

Acceptance publication date 1 September 2011

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/57 (2006.01) Medicinal preparations containing peptides

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/097165 Priority application(s): WO2005/097165

8 October 2009 Assignment before Grant

  ZymoGenetics, Inc. The application has been assigned to ZymoGenetics, Inc.; Bristol-Myers Squibb Company

3 June 2010 Corrigenda

  Assignments Before Grant, Section 113 - 2005 Delete all reference to Application No. 2005231476

1 September 2011 Application Accepted

  Published as AU-B-2005231476

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231478-Modulation of NKG2D

2005231470-Method and apparatus for dermatological treatment